Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studi (Q45398433)
Jump to navigation
Jump to search
scientific article published on 18 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studi |
scientific article published on 18 June 2013 |
Statements
1 reference
Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studi (English)
1 reference
1 reference
Jacqueline M Dekker
1 reference
Giel Nijpels
1 reference
Coen D A Stehouwer
1 reference
Casper G Schalkwijk
1 reference
Lian Engelen
1 reference
Marleen M J van Greevenbroek
1 reference
Carla J H van der Kallen
1 reference
Nordin M J Hanssen
1 reference
Maya S Huijberts
1 reference
Jean L J M Scheijen
1 reference
18 June 2013
1 reference
1 reference
Identifiers
1 reference